Quick answers
- What is Mupirocin used for?
- The FDA-approved label (Pirnuo, Glenmark Pharmaceuticals Inc., USA, March 20, 2020) says: “PIRNUO cream is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm 2 in area) due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Mupirocin have a boxed warning?
- No. None of the 42 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Mupirocin?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Mupirocin been recalled?
- FDA enforcement reports list 2 recalls of products of this medicine; the newest started August 30, 2024 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Mupirocin?
- 29 companies list prescription products of Mupirocin in the FDA NDC Directory, including Proficient Rx LP, Bryant Ranch Prepack and NuCare Pharmaceuticals, Inc..
What Mupirocin is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
PIRNUO cream is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm 2 in area) due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). …
— FDA label: Pirnuo, Glenmark Pharmaceuticals Inc., USA, effective March 20, 2020. Read the full label on DailyMed →
The FDA has 42 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 42 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Ointment · Cream |
|---|---|
| Route | Topical |
| Prescription products | 45 in the FDA NDC Directory |
| Brand names | Pirnuo |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| mupirocin 2% ointment | Generic | $0.1452–$0.2930 per gram 8 packages, lowest to highest |
| mupirocin calcium 2% cream | Generic | $0.8138–$0.8907 per gram 12 packages, lowest to highest |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Proficient Rx LP4 products
- Bryant Ranch Prepack3 products
- NuCare Pharmaceuticals, Inc.3 products
- Glenmark Pharmaceuticals Inc., USA3 products
- A-S Medication Solutions2 products
- Advanced Rx Pharmacy of Tennessee, LLC2 products
- Preferred Pharmaceuticals Inc.2 products
- Remedyrepack Inc.2 products
- Sportpharm LLC2 products
- Encube Ethicals, Inc.2 products
- Sun Pharmaceutical Industries, Inc.2 products
- Kesin Pharma Corporation1 product
- PAI Holdings, LLC dba PAI Pharma1 product
- Asclemed USA, Inc.1 product
- Hawaii Repack, Inc.1 product
- Direct_Rx1 product
- Padagis Israel Pharmaceuticals Ltd1 product
- Redpharm Drug1 product
- Teva Pharmaceuticals USA, Inc.1 product
- Atlantic Biologicals Corp.1 product
- AvPAK1 product
- Lohxa1 product
- St. Mary's Medical Park Pharmacy1 product
- Amneal Pharmaceuticals NY LLC1 product
- Zydus Lifesciences Limited1 product
- Alembic Pharmaceuticals Limited1 product
- Alembic Pharmaceuticals Inc.1 product
- Viona Pharmaceuticals Inc1 product
- NorthStar Rx LLC1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (11)
- ANDA065085Teva · November 7, 2003
- ANDA065123Padagis Israel · November 7, 2003
- ANDA065170Sun Pharma Canada · September 23, 2005
- ANDA090480Glenmark Pharms · June 8, 2011
- ANDA201587Glenmark Pharms · January 24, 2013
- ANDA207116Sun Pharma Canada · April 27, 2020
- ANDA213076Encube · August 31, 2021
- ANDA213053Alembic · November 16, 2021
- ANDA214811Amneal · November 15, 2022
- ANDA217943Encube · May 13, 2025
- ANDA218361Zydus Lifesciences · September 29, 2026
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
August 30, 2024 · Class II · Completed · D-0660-2024
Subpotent Drug
Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ, 07430, NDC 68462-180-22. — Glenmark Pharmaceuticals Inc., USA
-
April 13, 2022 · Class II · Terminated · D-1075-2022
cGMP deviations: Temperature abuse
Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA — Mckesson Medical-Surgical Inc. Corporate Office
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| RxCUI (RxNorm) | 106346, 311877, 2286614 |
|---|---|
| SPL set ID of the quoted label | 89c43f7b-1a88-45bf-a356-07518d4e7870 |
| FDA labels (SPL) | 42 |
| FDA applications | 11 ANDA |
| Active ingredients (FDA) | MUPIROCIN |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Pirnuo, Glenmark Pharmaceuticals Inc., USA, effective March 20, 2020; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →